Overview
Fenwick & West describes itself as purpose-built for technology and life-sciences companies at every stage of growth.[7] PitchBook credited it with 323 venture deals in 2025, tenth globally.[1] The firm states that it acted on more than 40% of the highest-value technology IPOs of 2025, citing Deal Point Data, and that it is business counsel to nearly half of US technology companies valued above US$25bn, citing PitchBook.[7] Its practice is concentrated on the companies themselves rather than on fund formation, and it has strong intellectual-property, tax and executive-compensation teams. For very early companies it competes directly with Cooley and Gunderson, though with a smaller annual deal count.
Fenwick & West strengths and limitations
Strengths
- Concentrated on technology and life-sciences companies
- Strong IPO track record in 2025
Limitations
- Lowest deal count of the ten in 2025
- Practice concentrated on two sectors, so less suited to startups outside technology and life sciences
Appears in
Fenwick & West alternatives and competitors
Alternatives to Fenwick & West: companies ranked in the same lists.
Gunderson Dettmer
Cooley
Goodwin- Orrick
- Wilson Sonsini Goodrich & Rosati
- DLA Piper
Silicon Legal Strategy- Pillsbury Winthrop Shaw Pittman
Latham & Watkins
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.